Search Results

0 results for 'Celgene'

You can use to get even better search results
January 13, 2020 | New York Law Journal

Antitrust Yearly Wrap-Up: Tech and Telecom in the Spotlight

Antitrust enforcement in numerous industries was robust in 2019. Aggressive and unexpected actions made headlines and proved that parties need to be prepared to meet any potential antitrust obstacles. In their Antitrust Trade and Practice column, Karen Hoffman Lent and Kenneth Schwartz recap the major events of 2019 and the issues to watch for in 2020.
10 minute read
December 31, 2019 | Corporate Counsel

Top Lawyers Make Year-End Exits: December 2019 In-House Moves

The end of the year brought high-level departures for Tesla Inc., Bed Bath & Beyond Inc. and The Coca-Cola Co. as general counsel retired or were hired elsewhere.
10 minute read
December 31, 2019 | Connecticut Law Tribune

In Connecticut and Beyond, Top Lawyers Make Year-End Exits

The end of the year brought high-level departures for Tesla Inc., Bed Bath & Beyond Inc. and The Coca-Cola Co. as general counsel retired or were hired elsewhere.
10 minute read
December 17, 2019 | Law.com

Skilled in the Art: Breaking Down a $752M Verdict with Morgan Chu + The Arthrex En Banc Petitions Are In + Is Supreme Court Clearing the Decks for a Section 101 Landing?

A conversation with Irell & Manella partner Morgan Chu about the $752 million jury verdict he just helped engineer last week.
14 minute read
December 17, 2019 | Litigation Daily

Irell's Morgan Chu Breaks Down a $752 Million Verdict Over Cancer Therapy

The IP litigator led a team of Irell & Manella and Jones Day attorneys in an eight-day trial on behalf of Juno Therapeutics and Memorial Sloan-Kettering Cancer Center. The companies had accused Kite Pharma of infringing a patent on ground-breaking CAR T immunotherapy.
7 minute read
December 17, 2019 | The Recorder

Morgan Chu Breaks Down a $752 Million Verdict Over Cancer Therapy

The IP litigator led a team of Irell & Manella and Jones Day attorneys in an eight-day trial on behalf of Juno Therapeutics and Memorial Sloan-Kettering Cancer Center. The companies had accused Kite Pharma of infringing a patent on ground-breaking CAR T immunotherapy.
7 minute read
December 05, 2019 | New York Law Journal

The Year in Review: The Maturing of the U.S. Market for Shareholder Activism

Shareholder activism has evolved to be a prominent, and almost certainly permanent, feature of the corporate landscape. As we approach the end of 2019, the maturity of the activism market in the United States is reflected not only in overall activity levels, but also in the infrequency of protracted public campaigns.
7 minute read
November 25, 2019 | The American Lawyer

Firms Feast on Pre-Thanksgiving M&A Deals in Finance, Luxury, Pharma Sectors

In a big day for M&A, Sullivan & Cromwell, Skadden, Paul Weiss, Allen & Overy, Davis Polk and Wachtell took roles advising on three deals totaling over $50 billion.
6 minute read
November 12, 2019 | New York Law Journal

Legal Integration Playbook: Strategic and Practical Information Governance Considerations in M&A

This article provides a playbook for the five key areas general counsel must address from a legal risk mitigation perspective, in partnership with records management and IT teams, during a merger or divestment.
6 minute read
October 15, 2019 | New York Law Journal

Rising Star: Rajeev Muttreja

Partner, Jones Day
2 minute read

TRENDING STORIES

    Resources

    • Corporate Transparency Act Resource Kit

      Brought to you by Wolters Kluwer

      Download Now

    • Revenue, Profit, Cash: Managing Law Firms for Success

      Brought to you by Juris Ledger

      Download Now

    • Law Firm Operational Considerations for the Corporate Transparency Act

      Brought to you by Wolters Kluwer

      Download Now

    • The Ultimate Guide to Remote Legal Work

      Brought to you by Filevine

      Download Now